Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Li Q, Zhang K, Yu Y, Yu Z, et al. TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma. PLoS One 2024;19:e0310889.
PMID: 39321199


Privacy Policy